CRM · Salesforce, Inc. · Stock research

Refresh of coverage first published 2026-07-30; last written 2026-08-08 with the shares at $192.74.

CRM — Salesforce, Inc.

Current Thesis

The leg on offer is still a de-rating reversal, but the marginal buyer since the last update arrived for a different reason. Between the 2026-08-07 close of $192.74 and the 2026-08-21 close of $209.17, no Salesforce-specific operating datapoint was released. What happened instead: Reuters reported on 2026-08-13 that Silver Lake is in talks to take Workday private, sending Workday to its best session since 2016 and a market value near $51B, and six sell-side desks moved their CRM targets between 2026-08-12 and 2026-08-20 (Wells Fargo $205, UBS $210, Citi $187→$204, BMO $230, Guggenheim $228, Cantor $250). A private-market bid for a de-rated mega-cap SaaS name reprices the whole group's floor, and CRM is the largest de-rated name in it.

That leaves the 2026-08-26 Q2 FY27 print, after the close, as the binary — and it now arrives with roughly eight percent less discount than the prior note described. Guidance issued 2026-05-27 was $11.27–$11.35B for the quarter and $45.9–$46.2B for FY27; previews dated 2026-08-20 put consensus near $3.27–$3.28 EPS on about $11.3B.

The narrative is maturing. The agentic story is fully distributed — Agentforce ARR crossed $1B in Q1 FY27 (2026-05-27) and every desk has an opinion on it. The 2026-08-12 to 2026-08-20 revision cluster is coverage marking to market days before a print, and three of those six revisions came from neutral-rated desks landing at $204–$210, essentially where the stock already traded on 2026-08-21. Fresh headline flow exists (2026-08-13 Workday), but it is sector M&A rather than new attention on this franchise, which has carried the "worst Dow performer" label since at least the 2026-07-25 Benzinga piece.

Bullish and bearish views on Salesforce, Inc.

The model's bull view on Salesforce, Inc. (CRM), in brief: Q1 FY27 (2026-05-27): revenue $11.13B, +13% Y/Y; cRPO $33.6B, +14% Y/Y; total RPO $67.9B, +11% Y/Y. Bookings growth ahead of reported revenue growth is the specific number the disruption case has to break on 2026-08-26. The bear view: The discount that made the case has partly closed before the event. Both cases follow in full.

Bull Case

• Q1 FY27 (2026-05-27): revenue $11.13B, +13% Y/Y; cRPO $33.6B, +14% Y/Y; total RPO $67.9B, +11% Y/Y. Bookings growth ahead of reported revenue growth is the specific number the disruption case has to break on 2026-08-26.
• FY27 revenue guidance raised to $45.9–$46.2B at the Q1 print, with non-GAAP diluted EPS guided $14.06–$14.12 and non-GAAP operating margin 34.3%. At the 2026-08-07 close of $192.74, stockanalysis.com screened forward P/E at 13.84; price is 8.5% higher on 2026-08-21, so the forward multiple has expanded from that level but remains far below the trailing 22.4x on EPS of $8.61.
• Cash generation and share-count shrinkage. Q1 FY27 free cash flow was $6.556B. The 2026-08-20 24/7 Wall St preview additionally cites a $25B accelerated repurchase with 103 million shares taken upfront, diluted share count falling from 970M to 871M over a year, 23 cents of Q1 EPS contribution and $25B of remaining authorization — third-party figures that the Q2 FY27 10-Q will settle.
• The VA award (2026-07-24) remains the only dated agentic dollar figure: $1.6B over three years, covering services for more than 17 million veterans. It drove a 7% session on 2026-07-27.
• Take-private optionality has been repriced for the group. Reuters, 2026-08-13: Silver Lake in talks on Workday, a deal that would rank among the largest software buyouts ever; Workday's value closed near $51B after the report. Benzinga's 2026-08-14 framing of a "SaaSpocalypse" opportunity captures the argument — de-rated distribution plus proprietary data attracts private capital.
• Bull-side targets moved up into the print: Cantor $250 (Overweight, 2026-08-20, VanVliet citing agentic-workflow share), BMO $230 (Outperform, 2026-08-20), Guggenheim $228 (Buy, 2026-08-20). Consensus sits near $242.74–$243.08 across ~51 analysts as of 2026-08-20.

Bear Case

• The discount that made the case has partly closed before the event. $192.74 on 2026-08-07 to $209.17 on 2026-08-21, RSI(14) at 67.6, a three-month price change of +16.5%, four sessions ahead of the print. Benzinga flagged $211 as resistance on 2026-07-28; the stock has not cleared it on a closing figure through 2026-08-21.
• Half the revision cluster is neutral desks chasing price. Wells Fargo Equal-Weight $205 (2026-08-12), UBS Neutral $210 (2026-08-12), Citi Neutral $187→$204 (2026-08-18, on channel checks showing modest Agentforce deployment improvement) — all at or below the 2026-08-21 close. Morgan Stanley's Equal-Weight and $185 target from 2026-07-21 has not been restored.
• A named, dated churn instance. Curative cancelled a $600,000 Salesforce contract, reported 2026-08-10, explicitly attributing the decision to AI changing the economics of building software in-house; Salesforce responded on security grounds. One contract is not a trend, but it is the first specific dollar cancellation attached to the build-versus-buy argument, and it followed UiPath's 13% drop on 2026-07-22 on OpenAI's "Presence" launch.
• A large holder exited in the quarter. Soros Fund Management dissolved its CRM stake per the 13F reported 2026-08-14.
• Bull calls have not stuck. A 2026-08-19 Tech Times piece makes the observable claim that prominent upgrade calls this year produced a pop and then gave it back, leaving the 2026-08-26 data as the test. The 2026-08-18 Benzinga item airing an expert view that Salesforce's and ServiceNow's business models are in danger shows the sceptical frame still has distribution.
• FY27 growth is partly inorganic. Informatica sits inside the reported FY27 growth rate, so the headline +13% Y/Y overstates the organic pace, and management has not quantified the split.

Setup & Price Structure

The 2026-08-21 close of $209.17 is 21.0% below the 52-week high of $264.88 — a materially smaller gap than the 27.2% recorded at the 2026-08-07 close. RSI(14) at 67.6 is the upper end of the range without being extended past 70. The structure since late July is a step-up from the $185–$193 area of early August into a shelf under the $211 level Benzinga identified on 2026-07-28, built without a company-specific catalyst.

Crowding and positioning observables, stated as observables: an earnings date four sessions away (2026-08-26, after close, 2:00pm PT call); six sell-side target revisions inside nine sessions (2026-08-12 to 2026-08-20); a wide target dispersion of $160 to $475 across 53 analysts as of 2026-08-07; a preview dated 2026-08-20 citing a potential 7% post-print move and a Polymarket-implied 91% probability of an earnings beat; a 13F exit by Soros Fund Management reported 2026-08-14. No Form 4 insider transactions and no equity issuance appeared in the filings reviewed for this window.

Catalyst Calendar (next 30 days)

• 2026-08-26 — Q2 FY27 earnings release after the close, webcast 2:00pm PT / 5:00pm ET. Guidance to beat: $11.27–$11.35B revenue; previews dated 2026-08-20 put consensus near $3.27–$3.28 EPS on ~$11.3B.
• 2026-08-26 — FY27 guidance reset in the same release. The $45.9–$46.2B revenue range and $14.06–$14.12 non-GAAP EPS range are the numbers the valuation case is underwritten against.
• ~2026-08-28 (est.) — Q2 FY27 10-Q filing, which settles the buyback and diluted-share-count figures currently circulating only in third-party previews.
• ~2026-08-27 to 2026-09-04 (est.) — post-print target revisions. Whether Morgan Stanley moves off $185 (set 2026-07-21) is the cleanest read on whether the bear underwrite has changed.
• ~2026-09-30 (est., unconfirmed) — resolution of the Silver Lake–Workday talks reported 2026-08-13. Reuters noted talks are ongoing with no guarantee of a deal.

What Would Change Our Mind

The August advance is what has to hold, and it was built on sector M&A plus target revisions rather than on anything Salesforce disclosed. Three things would break the read. First, the print passing without the arithmetic: a 2026-08-26 release that trims the $45.9–$46.2B FY27 revenue guide, or shows cRPO growth below the +14% Y/Y Q1 pace, removes the growth floor under the de-rating argument. Second, the take-private premium evaporating — the Silver Lake–Workday talks being reported dead, with the software group handing back the 2026-08-13 move, would remove the reason the last leg happened at all. Third, on price: a daily close below $192 hands back the entire pre-print August advance and returns the stock to the shelf it occupied before the revision cluster; a weekly close below $185 would additionally put the market beneath Morgan Stanley's 2026-07-21 target and undo the 2026-07-27 VA-contract session.

What would strengthen the read instead: a second federal agentic ELA at scale comparable to the $1.6B VA award, or management quantifying organic growth ex-Informatica above 10% on the 2026-08-26 call.

Correlation Notes

• Dow Jones Industrial Average component. Index flow is a persistent presence in the tape, independent of company news.
• The name trades with the de-rated SaaS complex. Workday's 2026-08-13 jump on the Silver Lake report and UiPath's 13% drop on 2026-07-22 on OpenAI's "Presence" launch are the two poles: private-market bid on one side, model-native disruption on the other. CRM has moved on both without issuing anything.
• Federal AI spending read-through. The $1.6B VA award (2026-07-24) landed in the same week Oracle's reported $7B defense deal was covered; federal agentic budgets are a shared driver across enterprise vendors.
• Rate sensitivity to the long-duration software multiple. The 2026-08-12 CPI print pushed September Fed hike odds to 33% per Benzinga's same-day coverage, and software names sold off on it.
• Salesforce Ventures activity is not a revenue signal. The 2026-08-20 Bloomberg item on Muon Space raising $250M with Google and Salesforce backing is balance-sheet participation, not a product datapoint.